Rapid Access to Preventive Intervention Development (RAPID)

Description:
RAPID supports the preclinical development of chemopreventive agents and clinical development through preclinical and Phase I studies by assisting investigators in the process of bringing discoveries from the laboratory to the clinic. Support provided includes:

• Chemical synthesis and GMP manufacturing
• Preclinical efficacy
• GLP toxicology testing
• IND preparation
• Phase 1 support

Web Site:
http://dcp.cancer.gov/programs-resources/programs/rapid


Availability:
Application process. Awards made on a competitive basis. Requests must be received by November 1 of each year.

Contact:
Izet Kapetanovic, Ph.D.; kapetani@mail.nih.gov

This page last updated 2007-11-08 14:00:22